Fig. 6
From: MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B
![Fig. 6](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs11658-019-0146-0/MediaObjects/11658_2019_146_Fig6_HTML.png)
Down-expression of TNFRSF1B reverses the effect of miR-125a-5p in RAW 264.7 cells. a RAW 264.7 cells that were treated with anti-miR-125a-5p and siTNFRSF1B were subjected to immunoblotting assay. b RAW 264.7 cells were treated with anti-miR-125a-5p alone or anti-miR-125a-5p in combination with siTNFRSF1B. The proliferation of RAW 264.7 cells was detected using MTT assay. c The migration of RAW 264.7 cells was determined by wound healing assay. d RAW 264.7 cells were treated with anti-miR-125a-5p alone or anti-miR-125a-5p in combination with siTNFRSF1B. The invasion of RAW 264.7 cells was analyzed by Transwell invasion assay. ** P < 0.01 compared to control, ## P < 0.01 compared to anti-miR-125a-5p